Delivery Order 36C24224D0048-36C24224N0566

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT) to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The award, Contract ID 36C24224D0048|36C24225N0194, has a ceiling value of $6,874.38 and is a Firm Fixed Price Delivery Order with an ultimate completion date of...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is a delivery order with a firm fixed price of $22,914.60 and a period of performance ending on December 31, 2024. The contract is for the delivery of the radiopharmaceutical product NETSPOT GA-68 to the Department of Veterans Affairs (VA), specifically the VA Integrated Service Network 2 (VISN 2). RLS (USA) Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of radiopharmaceuticals such as Gallium-68 Dotatate (NETSPOT) to the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $27,497.52 firm fixed-price delivery order has an ultimate completion date of August 31, 2025 and is not set-aside. RLS (USA) Inc. is a small business that holds several indefinite delivery vehicle (IDV) contracts with the VA and DHA,...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 21 to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $378,281.55, is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and the Defense Health Agency...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the supply of radiopharmaceuticals and related services. The $878,999.37 firm-fixed price contract is not set aside and has an ultimate completion date of September 17, 2024. RLS (USA) Inc. specializes in providing a wide range of molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear medicine...
This federal contract award, valued at $75,489.81, was issued by the Department of Veterans Affairs' Greater Los Angeles Healthcare System to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the delivery of Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical used in nuclear medicine imaging procedures, to the VA facility in Los Angeles, California. The contract was awarded as a firm-fixed-price purchase order with a period of performance from January 3, 2024...
This is a delivery order contract awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of NETSPOT GA-68, a radiopharmaceutical product used in nuclear medicine imaging procedures. The delivery order has a firm fixed price ceiling value of $43,537.74 and a performance period that runs through August 31, 2025. RLS (USA) Inc. is...
This federal contract award was issued by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is a Blanket Purchase Agreement (BPA) call for the procurement of 16 units of Gallium-68 Dotatate (NETSPOT), a radiopharmaceutical product critical for nuclear medicine imaging procedures. The award has a ceiling value of $48,000.00 and a firm-fixed-price type. RLS (USA) Inc. is an established supplier of radiopharmaceuticals to the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of radiopharmaceutical products. The contract has a ceiling value of $51,390.92 and a period of performance through December 31, 2024. The award is for the provision of critical radiopharmaceuticals, such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate (NETSPOT), which are used in...
This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
  • 36C24224D0048
    Indefinite Delivery Contract
  • 36C24224D0048-36C24224N0566
    Delivery Order

This contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the delivery of NETSPOT GA-68 radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $2,291.46 firm-fixed price contract has an ultimate completion date of August 21, 2024.

RLS (USA) Inc. holds several federal contract Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency to facilitate the efficient procurement of its radiopharmaceutical products, including technetium-99m, gallium-68 Dotatate, and other nuclear medicine imaging agents. These vehicles allow various VA medical centers and Defense Health Agency facilities to place orders for radiopharmaceuticals as needed, streamlining the acquisition process for these critical medical supplies. The IDVs have potential values ranging from hundreds of thousands to nearly two million dollars, with performance periods typically lasting three to five years.

Generated 8/21/24, 6:51 PM